Life Insurance
Consensus Index

AI Consensus Fit Review

Prudential Life Insurance Fit Review for Epilepsy and Seizure Disorders

Prudential is a good, but not conclusively best, fit for a U.S.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Prudential is a good, but not conclusively best, fit for a U.S. consumer with epilepsy or a seizure disorder who wants fully underwritten term or permanent life insurance and can document stable seizure control. Five of seven platforms named Prudential during the ranking stage (71.4% of included platform responses), at an average listed rank of 3.2 and a best rank of 1. The strongest reason to consider it is that Prudential's individual-life application directly asks about seizures and epilepsy, and independent reviewers describe its impaired-risk underwriting as flexible and individualized [1]. The main limitation is that no public source discloses Prudential's seizure-specific rating tables, approval rates, or premiums, so eligibility and cost can only be confirmed through underwriting.

Research Snapshot

FieldFinding
Platform mentions in ranking stage5 of 7 platforms (anthropic, deepseek, google, kimi, perplexity)
Share of included platform responses71.4%
Average listed rank3.2
Best listed rank1 (deepseek)
Relevant product/model/planFully underwritten individual life insurance, principally Term Essential or Term Elite term life; PruLife Essential Universal Life and other UL/IUL/VUL products as alternatives
Overall use-case fitGood (per openai, anthropic, google, kimi, perplexity); mixed (per deepseek, grok)
Research date2026-09-22

Why Prudential Qualified for This Study

Questions This Section Answers

  • Is Prudential a good choice for life insurance for epilepsy and seizure disorders?
  • Why did AI platforms include Prudential in a ranking of carriers for epilepsy life insurance?

Prudential qualified because its own application treats seizure history as a directly relevant underwriting factor, and because independent reviewers repeatedly place it among carriers used for complex medical histories. Prudential's individual life application asks whether the applicant has been treated for or diagnosed with a seizure, epilepsy, or other brain or nervous-system disorder [4]. That confirms the condition is reviewed rather than excluded from consideration.

Five of the seven included platforms named Prudential during ranking discovery, and it reached the finalist stage at an average listed rank of 3.2. Independent reviewers describe Prudential's impaired-risk underwriting as among the most flexible of any major carrier and note that for hard cases it is almost always on the shortlist an independent broker shops [5]. One broker-facing review states that a health history rated Table 4 elsewhere might be rated Standard at Prudential [7].

That said, no source explicitly names epilepsy as a Prudential underwriting specialty. The company's published materials emphasize flexibility for conditions such as diabetes, HIV, and heart disease, and epilepsy is not explicitly mentioned in public marketing or review materials [8]. Inclusion in this study reflects general impaired-risk capability plus direct acknowledgment of seizure history on the application, not proven seizure-specific superiority.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Epilepsy and Seizure Disorders

Questions This Section Answers

  • Which Prudential product should a buyer with epilepsy choose: Term Essential, Term Elite, or a permanent policy?
  • Does Prudential Term Essential require full medical underwriting for an applicant with a seizure disorder?

The most relevant Prudential product for this use case is fully underwritten individual term life insurance, principally Term Essential or Term Elite, with PruLife Essential Universal Life and other UL/IUL/VUL products as alternatives depending on underwriting results and coverage goals. Platforms converged on this product set, though naming was inconsistent.

Term Essential is a fully underwritten term product available through Prudential-related issuing companies. Public product material describes level-premium periods, annually increasing premiums after the level period, coverage ending at age 95, and conversion provisions subject to policy terms [9]. Prudential's EssentialTerm suite offers 10-, 15-, 20-, or 30-year term durations with guaranteed consistent premium payments throughout the selected term [10]. Coverage amounts range from $100,000 to $65 million [11].

Conversion is a meaningful feature for this buyer. Term policies can convert to a Prudential permanent policy within the first seven years, or until age 70, whichever comes first, maintaining the same health underwriting classification [12]. One independent review states Term Essential is convertible to permanent coverage without new medical underwriting, with conversion timing rules [14]. For a buyer whose seizure control may change over time, that preserves insurability.

Permanent alternatives include PruLife Essential Universal Life, which has face-amount bands, minimum face amounts, and a no-lapse guarantee structure described in the product material [15]. Prudential's filing identifies multiple individual-life product forms, including EssentialTerm, PruLife Essential Universal Life, VUL, IUL, and other permanent-life products [16].

One naming conflict matters for buyers: the requested product list includes Term Elite, but the current public product material located and relied upon was for Term Essential. Current Term Elite availability and specifications are unclear (openai). Buyers should confirm which term form is actually being offered in their state.

What the AI Platforms Agreed About

Questions This Section Answers

  • Do AI platforms agree that Prudential is a good fit for life insurance with epilepsy?
  • What underwriting factors do platforms say Prudential considers for a seizure disorder applicant?

Platforms agreed on several points, though the agreement was strong rather than unanimous.

First, Prudential is a credible, financially strong carrier. Prudential holds an A+ (Superior) rating from A.M. Best, AA- (Very Strong) from Standard & Poor's, and AA- (Very Strong) from Fitch [17]. One platform describes Prudential as a large, highly rated US life insurer [18].

Second, seizure history is directly relevant to Prudential underwriting. Prudential's application asks about seizures, epilepsy, and other neurological disorders and permits additional health information to be requested [19]. Prudential's underwriting materials list epilepsy and seizures among major medical conditions requiring full underwriting [20].

Third, the underwriting factors that matter are consistent across platforms and match the use case: seizure type, frequency, time since the most recent seizure, medications, treatment compliance, neurological evaluation, and driving restrictions. Independent epilepsy-focused reviews state that underwriters view epilepsy through the lens of seizure control and consistency, and that a person seizure-free for multiple years on stable medication represents a very different risk profile than someone with recent breakthrough seizures [21]. Insurers review whether antiepileptic medications are taken consistently and how well the drugs control seizures; missing doses or frequent medication changes in the past two years signal poor control to underwriters [23].

Fourth, Prudential's general underwriting posture is individualized rather than chart-driven. Independent reviewers state Prudential takes a clinical, individualized view of conditions rather than applying rigid charts, and that Prudential Financial strives to be competitive in impaired risk underwriting [25].

Fifth, full underwriting is expected. Complex histories usually still require full underwriting with labs and physician statements [27]. Prudential's underwriting guide states that MD exams may be required based upon the underwriter's discretion, and that some medical conditions may be rated [28].

Where the AI Platforms Disagreed or Were Uncertain

Platforms disagreed on overall fit rating and on how much seizure-specific underwriting detail actually exists.

Fit ratings split. Five platforms rated Prudential a good fit (openai, anthropic, google, kimi, perplexity). Two rated it mixed (deepseek, grok). The mixed ratings reflect the absence of published epilepsy-specific underwriting standards rather than any negative finding about Prudential.

The sharpest disagreement concerns whether Prudential publishes seizure-specific rating criteria. One platform reported detailed rating schedules: for complex partial or generalized tonic-clonic seizures, a Table D rating within 2 years of the last seizure, a Table B rating from the third through fifth year, and non-rated coverage after 5 years seizure-free; for generalized absence and simple partial seizures, a Table B rating if the last seizure occurred within 2 years and non-rated coverage after more than 2 years seizure-free [30]. A separate broker summary reported Preferred Best possible after 5 years seizure-free, with Table 2-4 for 2+ years seizure-free and Standard possible in mild cases [31].

Other platforms explicitly stated the opposite: no public Prudential underwriting guide or rate manual specifically addresses epilepsy or seizure disorder rating criteria, rating tables, or typical approval outcomes (anthropic). One platform stated that Prudential's public materials do not publish epilepsy- or seizure-specific underwriting classes, rates, or a stated acceptance policy (deepseek). Another noted that the underwriting guide source is not clearly a consumer-facing Prudential page, so its applicability to every current product and state is not fully verifiable (perplexity).

This is a genuine factual conflict, not a consensus. The detailed rating schedules come from third-party and broker sources, not from a verified current Prudential consumer disclosure. Buyers should treat any specific table rating as unverified until confirmed in an individual underwriting offer.

Platforms also disagreed on accelerated underwriting. One platform reported that Prudential's accelerated underwriting program is available for eligible applicants between the ages of 18 and 60 [33]. Another stated that accelerated underwriting is almost certainly unavailable for epilepsy applicants, requiring full paramed and physician underwriting (anthropic). Prudential's own page states that availability of coverage and rates varies based on company underwriting criteria including age, sex, health history, smoking status, and residency [34].

Finally, one platform raised a diligence point unrelated to epilepsy: Prudential has faced regulatory scrutiny and litigation over certain claims issues in recent years [35]. This is not specific to seizure-disorder underwriting.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does Prudential Term Essential offer a buyer with epilepsy who may need to convert coverage later?
  • Does Prudential offer living benefits or riders that matter for someone with a seizure disorder?

Prudential's relevant capabilities for this use case are full medical underwriting, term-to-permanent conversion, and living-benefit riders.

Full underwriting is the core capability. Prudential's application asks about seizures and epilepsy, and its underwriting model can evaluate medical information rather than relying only on guaranteed-issue rules [36]. Prudential states that some applicants may not need a medical exam, while describing underwriting interviews and electronic collection of medical information [37]. However, that statement does not establish guaranteed acceptance or favorable treatment for epilepsy.

Conversion rights are the second capability. Term policies offer the flexibility to convert to any permanent product within the first seven years, or until age 70, whichever comes first [38]. Clients can convert to a designated permanent product in year eight through the end of their term, or to age 70, whichever comes first [39]. Conversion maintains the same health underwriting classification [40].

Riders are the third. A terminal illness rider is automatically included on many products, allowing access to a portion of the death benefit if the policyholder becomes terminally ill [41]. Optional riders include waiver of premium in the event of disability, an accidental death benefit, and convertible life insurance for a child [41]. Prudential markets living-benefit riders on eligible policies, and its universal life page references Living Needs Benefit and BenefitAccess Rider for terminal or chronic illness [43].

Payment flexibility is a minor but practical feature. Term Essential payment modes include annual, semiannual, quarterly, and monthly electronic-funds-transfer options; the product material states that nonannual payment modes may produce higher aggregate premiums [45].

Two capability limits matter. First, no guaranteed-issue or no-exam epilepsy product was identified from Prudential (deepseek). Second, product availability, issuing company, riders, and terms vary by state; Term Essential materials state that product availability and issuing-company details vary by state [45].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Prudential life insurance cost per month for an applicant with epilepsy?
  • What fees and contract terms should a buyer with a seizure disorder confirm before signing with Prudential?

No reliable seizure-specific premium can be stated. Prudential's public materials describe underwriting-based pricing but do not publish a usable epilepsy-specific rate table (openai). Prudential does not publish epilepsy-specific life insurance premiums or rating classes; quotes are individualized (deepseek). Pricing confidence across platforms was low.

For context on standard-health pricing, one independent review reports that Prudential's term life rates are competitive at $500,000 and above but above average at lower coverage amounts, and that a 40-year-old woman buying a $500,000 policy pays $46 per month, within $1 of the national average [46]. That figure is not an epilepsy quote and should not be treated as one.

For impaired-risk cases, the pricing mechanism is the rating class rather than the rate card. One independent review states that a health history that gets Table 4 elsewhere might get Standard at Prudential, which beats any healthy-shopper discount [48]. Industry data cited by one platform shows different carriers can rate the exact same seizure disorder two to four tables apart, and that on a permanent policy the gap could mean tens of thousands of dollars over the life of the contract [49].

Known cost mechanics:

  • Term Essential premiums increase annually after the level-premium period and are not guaranteed for the remainder of the policy [52].
  • Coverage ends at age 95 according to the cited Term Essential product material [52].
  • Optional riders may cost extra (openai).
  • Permanent-life products may contain policy charges and non-guaranteed elements described in the contract and illustration (openai).
  • Universal life cost-of-insurance and expense charges can reduce cash value, and underfunding can cause lapse (deepseek).

Contract and cancellation terms:

  • Conversion rights are subject to product and policy limits, including stated age or period restrictions (openai).
  • Free-look, lapse, reinstatement, surrender, and cancellation terms vary by policy and state and should be confirmed in the policy (openai).
  • Policy lapses if premiums are not paid; reinstatement may require new underwriting (anthropic).
  • Face amount decrease is allowed at any time after policy issue, provided total coverage stays above company minimum (anthropic).

Medical exam and lab costs are typically paid by the insurer as part of underwriting, not by the applicant, though this should be verified (deepseek). One platform noted that attending physician statement request fees may be incurred by the applicant (anthropic).

Best Suited For

Questions This Section Answers

  • Who is Prudential best suited for among buyers with epilepsy or a seizure disorder?
  • Is Prudential a good fit for someone with well-controlled epilepsy who wants term life insurance?

Prudential is best suited for applicants with stable, well-documented seizure control who want fully underwritten coverage and are willing to complete medical underwriting.

Platforms converged on this profile:

  • Applicants seeking medically underwritten term coverage who have stable, well-documented seizure control (openai).
  • Applicants willing to provide neurologist records, medication history, treatment-compliance information, and other underwriting evidence (openai).
  • Applicants with well-controlled epilepsy on stable medication regimens seeking term life insurance through brokers (anthropic).
  • Applicants whose epilepsy qualifies them as high-risk candidates who may receive better ratings from Prudential than from standard carriers (anthropic).
  • Conversion-focused buyers wanting to switch from term to permanent coverage without additional medical underwriting (anthropic).
  • Individuals with controlled epilepsy, typically seizure-free 2+ years with stable medications and good compliance, seeking fully underwritten term or universal life (kimi).
  • Individuals with well-controlled simple partial or absence seizures who have been seizure-free for at least 2 years, and applicants with generalized tonic-clonic or complex partial seizures seeking standard rates after being seizure-free for 5 years (google).

The common thread is documentation. Someone who takes medication consistently, sees a neurologist regularly, and maintains seizure freedom demonstrates they can manage their health long term [53]. People on a stable medication regimen with no seizures for several years qualify for better rates [54].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Prudential for life insurance with epilepsy?
  • Is Prudential a poor fit for someone with recent or uncontrolled seizures?

Prudential is probably not the best fit for applicants who need guaranteed approval, have recent or uncontrolled seizures, or lack documentation.

Platforms identified these groups:

  • Applicants needing guaranteed approval, no medical underwriting, or immediate certainty about eligibility (openai).
  • Applicants with recent, frequent, unexplained, or poorly documented seizures who need broad impaired-risk shopping across multiple carriers (openai).
  • Applicants primarily seeking the lowest premium without first comparing seizure-specific underwriting outcomes (openai).
  • Recent-onset epilepsy (less than 6 months post-diagnosis) or recent seizure events (less than 3-6 months) (anthropic).
  • Applicants with very frequent uncontrolled seizures (more than seven per year) who may qualify only for final expense insurance (anthropic).
  • Applicants seeking simplified issue (no medical exam) non-disclosure policies, as epilepsy requires full underwriting assessment (anthropic).
  • Buyers with frequent, recent or poorly controlled seizures who likely need an impaired-risk or guaranteed-issue carrier (deepseek).
  • Buyers who want a company with published, epilepsy-specific underwriting guidelines or a stated willingness to insure seizure disorders (deepseek).
  • Individuals with recent seizures (under 12 months) seeking immediate fully underwritten approval, and those needing guaranteed acceptance regardless of seizure history (kimi).
  • Applicants diagnosed with status epilepticus or metabolic brain disease within the last 5 years, and individuals with poorly managed epilepsy experiencing more than 6 seizures per year (google).

One independent source states that if epilepsy was first diagnosed in the last six months, or if seizures exceed seven per year, coverage options may be limited to final expense insurance [55].

When Another Option May Be Better

Questions This Section Answers

  • When is a different carrier or broker better than Prudential for a buyer with a seizure disorder?
  • Should a buyer with recent seizures use a guaranteed-issue policy instead of Prudential?

Another option may be better in several specific situations.

Use an independent impaired-risk broker when the applicant has recent seizures, multiple seizure types, medication changes, an unclear diagnosis, abnormal neurological findings, or prior declines (openai). Compare carriers with documented experience in seizure-disorder underwriting when the priority is the best possible rating rather than a particular company (openai).

Consider guaranteed-issue or simplified-issue coverage only when traditional underwriting is unavailable or unacceptable, while comparing lower limits, higher cost, waiting periods, and exclusions (openai). One platform notes that if a Table 8+ rating is received, simplified issue may cost less than heavily rated traditional coverage (kimi). Final expense options with level or graded coverage exist for epilepsy, including guaranteed issue with a 2-year waiting period as an alternative [56].

Consider employer-sponsored group life when available, but verify portability, evidence-of-insurability requirements, coverage limits, and whether the coverage remains after employment (openai).

Specialty high-risk or final expense policies may be the only viable options when seizure onset is recent (under 6 months) or seizures are very frequent and uncontrolled (more than 7 per year) (anthropic). Applicants with refractory epilepsy or complex multi-system neurological disease may find that specialty carriers focused exclusively on high-risk medical conditions have more developed underwriting guidelines (anthropic).

Applicants shopping only on preferred-health rates should note that carriers specializing in healthy applicants offer lower rates for standard-risk profiles (anthropic). Prudential's pricing advantage lies in impaired-risk cases, not healthy applicants.

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Prudential before signing a life insurance contract with a seizure disorder?
  • How can an applicant with epilepsy verify Prudential's underwriting outcome before committing?

These questions come directly from platform-reported verification lists and should be answered in writing before a formal application.

  1. Which legal insurer will issue the policy in the applicant's state (openai)?
  2. Is the proposed product currently available in the applicant's state, and is it Term Essential, Term Elite, or another term form (openai)?
  3. How will the underwriter evaluate seizure type, date of last seizure, frequency, triggers, EEG or imaging results, medication changes, compliance, neurologist follow-up, and driving restrictions (openai)?
  4. Will Prudential request an attending-physician statement, neurologist records, pharmacy data, motor-vehicle records, exam, EEG, or other testing (openai)?
  5. What underwriting class, table rating, exclusions, or postponement is being offered, and can the application be informally reviewed before a formal submission (openai)?
  6. What are the guaranteed premiums during and after the level term period, and what is the total cost under annual versus monthly payment (openai)?
  7. What conversion rights apply, what products are available for conversion, and what deadlines or age limits apply (openai)?
  8. For UL, IUL, or VUL, which charges and values are guaranteed, which are non-guaranteed, and what premium is required to prevent lapse under adverse assumptions (openai)?
  9. Are riders available, what do they cost, and do any seizure-related facts affect rider eligibility (openai)?
  10. What are the free-look, cancellation, lapse, reinstatement, contestability, and suicide-clause terms under the policy and state law (openai)?
  11. What is Prudential's minimum seizure-free period required to avoid a rated table, and does 12, 24, or 36+ months apply to the applicant's seizure type (anthropic)?
  12. Will the case qualify for accelerated underwriting, or will full paramed and physician underwriting be required, and what is the expected timeline (anthropic)?
  13. Are there any seizure-related exclusions, limitations, or riders Prudential requires, such as an exclusion for seizure-related death (anthropic)?
  14. If declined by Prudential, what alternatives would the broker recommend (anthropic)?
  15. Does Prudential have any published or internal underwriting guidance for epilepsy, and what seizure-free duration or control thresholds apply (deepseek)?
  16. How do competing carriers with published epilepsy guidelines compare on premium and approval odds (deepseek)?
  17. What is the specific rate class or offer based on seizure history, last seizure date, and medications (grok)?
  18. Are there postponement periods or additional requirements like EEG or neurologist reports (grok)?
  19. What is Prudential's current minimum seizure-free period for standard or mild table rating on fully underwritten term (kimi)?
  20. What table rating was actually assigned, and how does it compare to simplified issue or guaranteed issue alternatives (kimi)?

Final AI Consensus Verdict

Prudential is a good fit for a consumer with epilepsy or a seizure disorder who is seeking fully underwritten term or permanent life insurance and can provide complete, current medical documentation. Five of seven platforms rated it a good fit; two rated it mixed. The strongest evidence is that Prudential's application directly asks about seizures and epilepsy, and that independent reviewers consistently describe its impaired-risk underwriting as flexible and individualized.

Prudential is not proven to be the best epilepsy carrier. Public evidence does not disclose seizure-specific underwriting outcomes, rating tables, or comparative pricing, and platforms disagreed about whether such criteria exist publicly at all. The buyer should seek an informal underwriting assessment and compare multiple impaired-risk carriers before purchase. Recent-onset, uncontrolled, or poorly documented seizures may point toward specialty high-risk carriers, simplified issue, or final expense coverage instead.

How This Review Was Produced

This review synthesizes platform-reported research from seven AI platforms, each of which independently evaluated Prudential's fit for Life Insurance for Epilepsy and Seizure Disorders. Five platforms named Prudential during the ranking stage. Each platform supplied its own citations, fit rating, product identification, pricing notes, and verification questions. Fit ratings were aggregated as reported. No platform conducted personal testing, and no platform independently verified Prudential's seizure-specific underwriting outcomes. All factual claims are attributed to the platform that reported them.

Methodology Limitations

Several limitations apply. Platform-reported research dates differ from the authoritative run date of 2026-09-22; one platform reported a research date of 2026-01-15, and platform-reported dates are provenance metadata that do not independently prove freshness. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. One platform ran without search enabled, so its claims require explicit verification before being described as current facts.

Platforms disagreed on whether Prudential publishes seizure-specific rating criteria. Detailed rating schedules reported by one platform and one broker summary conflict with explicit statements from other platforms that no such public criteria exist. This conflict is unresolved and should not be treated as consensus.

No public source discloses Prudential's epilepsy-specific approval rates, rating tables, or premiums. Product naming is inconsistent across platforms, and current Term Elite availability and specifications are unclear. Prudential-related products may be issued by Pruco Life Insurance Company, Pruco Life Insurance Company of New Jersey, or another Prudential entity depending on product and state. Platform agreement on fit does not prove product quality or underwriting outcomes.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Additional AI research evidence56 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:14-3
    3. AI research evidence record anthropic:14-4
    4. AI research evidence record openai:c1
    5. AI research evidence record anthropic:14-3
    6. AI research evidence record anthropic:14-6
    7. AI research evidence record anthropic:14-12
    8. AI research evidence record anthropic:14-4
    9. AI research evidence record openai:c3
    10. AI research evidence record anthropic:18-1
    11. AI research evidence record anthropic:31-10
    12. AI research evidence record anthropic:18-2
    13. AI research evidence record anthropic:32-3
    14. AI research evidence record anthropic:16-2
    15. AI research evidence record openai:c4
    16. AI research evidence record openai:c5
    17. AI research evidence record anthropic:34-8
    18. AI research evidence record deepseek:c1
    19. AI research evidence record openai:c1
    20. AI research evidence record perplexity:c1
    21. AI research evidence record anthropic:5-3
    22. AI research evidence record anthropic:5-4
    23. AI research evidence record anthropic:37-1
    24. AI research evidence record anthropic:37-2
    25. AI research evidence record anthropic:14-4
    26. AI research evidence record anthropic:15-3
    27. AI research evidence record anthropic:14-10
    28. AI research evidence record anthropic:23-5
    29. AI research evidence record anthropic:23-9
    30. AI research evidence record google:1.2.2
    31. AI research evidence record grok:0
    32. AI research evidence record grok:1
    33. AI research evidence record anthropic:22-8
    34. AI research evidence record anthropic:21-5
    35. AI research evidence record deepseek:c6
    36. AI research evidence record openai:c1
    37. AI research evidence record openai:c6
    38. AI research evidence record anthropic:32-3
    39. AI research evidence record anthropic:32-9
    40. AI research evidence record anthropic:18-2
    41. AI research evidence record anthropic:18-4
    42. AI research evidence record anthropic:32-10
    43. AI research evidence record deepseek:c5
    44. AI research evidence record perplexity:c4
    45. AI research evidence record openai:c3
    46. AI research evidence record anthropic:28-1
    47. AI research evidence record anthropic:28-2
    48. AI research evidence record anthropic:14-12
    49. AI research evidence record anthropic:39-6
    50. AI research evidence record anthropic:39-7
    51. AI research evidence record anthropic:39-8
    52. AI research evidence record openai:c3
    53. AI research evidence record anthropic:5-7
    54. AI research evidence record anthropic:37-3
    55. AI research evidence record anthropic:3-1
    56. AI research evidence record kimi:palmetto

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
42
Ranking mentions
5 of 7
Platform share
71%
Final consensus rank
#4

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

22 independent · 19 company-owned · 1 unclear

Evidence support

29 direct · 11 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

7fb169c95d445ff6ffd7b504f1cf70e06dc0fcf835156432675493404c7e3329